Jamie Goldstein is a founding partner at Pillar VC who co-founded an AI speech recognition startup in the 1990s that was acquired by Nuance, and now serves as Founder & Chairman of Petri, a biotech company-creation platform focused on founder-led bio companies. He co-leads Encode: AI for Science, backing companies at the intersection of AI and computational biology, and regularly publishes tactical content for founders on VC mechanics like term sheet negotiation and board dynamics.

• Deep commitment to the Boston ecosystem, frequently highlighting local innovations and advocating for infrastructure improvements within the city. This includes championing the introduction of autonomous vehicle services like Waymo to the area or celebrating local robotics developments.
• Preference for humble, execution-focused founders over those seeking the spotlight. A recurring theme involves comparing the work ethic of Boston entrepreneurs, who are described as doing the majority of the work while crediting the team, favorably against the perceived egoism of Silicon Valley counterparts.
• Focus on backing "hard tech" and scientific breakthroughs that spin out of major research institutions, particularly MIT and Harvard. Investments often center on complex challenges, such as underground ammonia production developed by professors or semiconductor collaboration networks.
• Hands-on experimentation with modern AI tools to build software. There is a clear interest in using coding assistants like Claude to personally create applications, such as a location-sharing tool for friends, demonstrating a practical engagement with the technology rather than just financial observation.
• Value placed on resilience and the ability to navigate crises. High praise is reserved for leadership teams that have endured significant hardships, such as IP theft, lawsuits, or pivots, yet managed to steer their companies to successful acquisitions.
• Pride in portfolio companies that deliver tangible societal impact, particularly in healthcare and life sciences. Highlights include backing firms responsible for modernizing medical testing procedures like the Pap test, which has led to countless lives saved.